BridgeMD
New treatment option for Delusional Disorder
Official title FEEL-GOOD: A Multicenter Trial of a Mindfulness-Based Group Therapy in Young Adults With Early Psychosis
ClinicalTrials.gov ID: NCT07645443
What this study is testing
- What it's testing
- FEEL-GOOD is a prospective multi-site single-blinded randomized controlled trial in young inpatients with acute early psychosis. Participants are randomized 1:1 to FEEL-GOOD plus treatment as usual (TAU) or TAU alone.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 16 to 35
You may be able to join if
- Age 16 to 35 years
- Clinical diagnosis of early psychosis, defined as first psychotic episode within the last 5 years as assessed with the Structural Clinical Interview...
- DSM-5 schizophrenia spectrum or other psychotic disorder confirmed with SCID-5-RV (DSM-5: 297.1, 298.8, 295.4, 295.9, 295.7, 298.8, 298.9) Currently...
- Interested in and willing to participate in FEEL-GOOD and/or TAU.
You likely can't join if
- Insufficient German language abilities
- Acute suicidality or acute threat to others
The study team makes the final eligibility decision.
Where it's taking place
- Mannheim, Baden-Wurttemberg, Germany
- Augsburg, Bavaria, Germany
- München, Bavaria, Germany
- Hamburg, Free and Hanseatic City of Hamburg, Germany
- Marburg, Hesse, Germany
- Cologne, North Rhine-Westphalia, Germany
- Berlin, State of Berlin, Germany
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 16 years to 35 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Mannheim, Baden-Wurttemberg, Germany; Augsburg, Bavaria, Germany; München, Bavaria, Germany; Hamburg, Free and Hanseatic City of Hamburg, Germany; Marburg, Hesse, Germany; Cologne, North Rhine-Westphalia, Germany and 1 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.